Livin, a novel member of inhibitor of apoptosis proteins (IAP), is overexpressed in a variety of tumor tissues. Investigation of its structure and function, and its mechanisms of action has important significance for understanding the occurrence and development of the tumors and anticancer drug screening as well as treatment planning and prognosis estimation for cancers. This paper overviews the recent progress in the above relevant issues.